Where trials lose participants
- 01Outreach timing drifts by site and coordinator bandwidth.
- 02Protocol exception context is fragmented across email and local trackers.
- 03Escalations arrive too late for intervention windows.
TrialWeave gives biopharma operations teams one operational layer for participant adherence, site-level escalation, and compliant communication history across global studies.
Built for GCP-grade programs, late-phase studies, and multi-CRO collaboration.
A procurement-friendly operating layer for biopharma, CRO, and site collaboration.
Problem and response surfaces are separated clearly so program leads can see where risk is introduced and how it is closed.
Feature rows are intentionally dense and table-like to support quick evaluation by trial operations and compliance stakeholders.
Participant-level risk scoring with protocol-window weighting and communication decay signals.
Live scheduling and missed-window detection by site, arm, and milestone to prevent cascading delays.
Consent-aware messaging templates with immutable audit trails across participant communication channels.
Real outcomes from trial operations leaders managing global programs.
"Our retention watchlist is now actionable by noon instead of buried in end-of-day reports. The effect on mid-study continuity is material."
"TrialWeave gave us a single source of truth for site-level escalation and made QA review dramatically simpler."
"The participant communication ledger helped us pass sponsor review with minimal manual evidence prep."
Bring one ongoing study and we will map your current retention process into a pilot operating model in under two weeks.